Takeda Pharmaceutical Company Limited announced on
July 1, 2008 that Takeda Pharmaceuticals North America, Inc. and Takeda
Global Research & Development Center, Inc. merged with TAP
Pharmaceutical Products Inc. (TAP), forming one of the top 15
pharmaceutical companies in the United States.
The merger is a result of the conclusion of a 30-year joint
venture between Takeda Pharmaceutical Company Limited and Abbott
announced March 19, 2008. According to terms previously announced,
Takeda received the rights to TAP’s product Prevacid, its non-Lupron
related commercial organization, TAP's support organizations, and TAP’s
pipeline.
|